# Ultragenyx Pharmaceutical Inc.: Form 8-K, filed May 19, 2025

- Company: [Ultragenyx Pharmaceutical Inc.](/companies/rare.md) (CIK 1515673)
- Form: 8-K
- Filed: 2025-05-19
- Accepted by EDGAR: May 19, 2025, 17:03 ET
- Period: 2025-05-15
- Accession: 0000950170-25-074529
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1515673/000095017025074529/rare-20250515.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1515673/000095017025074529/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1515673/000095017025074529/rare-20250515.htm

Filed May 19, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-074529. Last ingested by Listed: Nov 3, 2026, 19:02 ET. No prices; not investment advice.